Results 221 to 230 of about 1,839,456 (290)

Use of Systemic Glucocorticoids and Risk of Prostate Adenocarcinoma: Evidence From a Danish Population-Based Case-Control Study. [PDF]

Cancer Med
Olivier E, Hicks B, Olesen M, Fournier A, Severi G, Pottegård A, Cairat M.   +6 more
europepmc   +1 more source

Topoisomerase I Inhibition in ETV4‐overexpressed Non‐Small Cell Lung Cancer Promotes Replication and Transcription Mediated R‐Loop Accumulation and DNA Damage

Advanced Science, EarlyView.
The oncogenic ETS factor ETV4 exerts a pleiotropic control over DNA replication both in a transcription‐dependent and ‐independent fashion in NSCLC cells. High‐ETV4 expression leads to R‐loop formation and DNA damage in response to TOP1 inhibition.
Jiaxi Zhang, Yan Wang, Shanhu Cao, Shelly M. Xie, Bei Liu, Yimeng Li, Yuqi Hou, Xue Meng, Mingzhu Ruan, Di Bu, Jia Kang, Ruxin Li, Lei Lou, Juan Wang, Lingxiao Xing   +14 more
wiley   +1 more source

Treatment of the Prostatic Cancer with “Suron (Hexoesterol)” in Large Dosis

, 1951
Takaharu Ichikawa, Motohiro Murakami
openalex   +2 more sources

Obstructive Ureteral Metastasis From Prostate Cancer. [PDF]

Clin Case Rep
Al-Bitar A, Senjab A, Alhamwy Z, Al Attar MR, Al Tawil M.   +4 more
europepmc   +1 more source

USP10 Inhibits Ferroptosis via Deubiquinating POLR2A in Head and Neck Squamous Cell Carcinoma

Advanced Science, EarlyView.
This study identifies USP10 as a novel deubiquitinase that antagonizes ferroptosis in head and neck squamous cell carcinoma (HNSCC). Mechanistically, USP10 directly stabilizes POLR2A protein through post‐translational deubiquitination, enabling POLR2A‐mediated transcriptional activation of SLC7A11, a key ferroptosis inhibitor.
Diekuo Zhang, Xueying Wang, Shanhong Lu, Yan Gao, Gangcai Zhu, Guo Li, Zongnan Yu, Junwei Hou, Helei Yan, Wenhui Yuan, Xin Zhang, Mien‐Chie Hung, Zhifeng Liu, Yong Liu   +13 more
wiley   +1 more source

OBSERVATION ON HISTOLOGICAL PICTURE AND CONTENT OF COLLAGEN IN PROSTATIC HYPERTROPHY AND PROSTATIC CARCINOMA

, 1959
Sadakazu Nomura
openalex   +2 more sources

TMEM16A in prostate cancer: mechanistic insights and therapeutic implications. [PDF]

Cancer Cell Int
He JW, Li PZ, Huang ZX.
europepmc   +1 more source

Epigenetic Activation of CCDC183‐AS1 Promotes Osteoclastogenesis and Prostate Cancer Bone Metastasis Through the FUBP1/LIGHT Axis

Advanced Science, EarlyView.
CCDC183‐AS1 overexpression enhanced the ability of PCa cells to spread to the bone by inducing osteoclastogenesis. Mechanistically, CCDC183‐AS1 interacted with FUBP1 and enhanced its stability, which promoted the transcription of TNFSF14 (LIGHT). Copy number gain‐induced KDM5C epigenetically upregulated CCDC183‐AS1 expression by recruiting TET1 to the ...
Chuandong Lang, Xiangyu Mu, Kun Chen, Xinwen Wang, Yuluo Rong, Jia Wang, Zongcheng Yang, Chi Yin, Yuhu Dai, Jun Xiao, Wenzhi Zhang   +10 more
wiley   +1 more source

The Diseases of the Prostate, their Pathology and Treatment. [PDF]

Henry Thompson, W. F. A.
openalex   +1 more source

AR to GR switch modulates differential TDO2-Kyn-AhR signalling to promote the survival and recurrence of treatment-induced dormant cells in prostate cancer. [PDF]

Cell Discov
Li S, Zhang Y, Luo M, Zhou W, Chen Y, Wu D, Wei Q, Chang Y, Hu H.   +8 more
europepmc   +1 more source